Loading
Latest filing published 06 Jan 2023 for Kintara Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Dennis M. Brown span 2 companies, the busiest being Cell Source, Inc. and TuHURA Biosciences, Inc./NV. Over a trading history stretching from 31 December 2019 to 5 January 2023, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 6 January 2023 came the latest disclosure, a transaction in TuHURA Biosciences, Inc./NV. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations